Tirzepatide: The Dual Agonist That Changed the Whole Conversation

Tirzepatide is the GLP-1 that actually broke through. Semaglutide was the headline, but tirz was the one that made people who had never succeeded on a diet lose 20% of their body weight and keep it off for a year. SURMOUNT-1 posted 22.5% mean weight loss. That number rewired the obesity-care conversation, and it's still the reason half of the "my doctor put me on..." threads you read are specifically about tirz.

This is the field guide: what the community actually does with it, what the data says, and where the cracks are.

What it is, in one paragraph

Tirzepatide is a 39-amino-acid peptide that hits both the GIP and GLP-1 receptors — a "twincretin." Roughly 5:1 in favor of GIP, but enough GLP-1 activity to do the central appetite work that GLP-1s are known for. Once-weekly, albumin-bound via a C20 fatty diacid, half-life around 5 days. FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management. It's the current gold standard for pharmacologic weight loss.

Dosing: what people actually do

The approved titration is the map. Deviating from it mostly hurts.

• Weeks 1–4: 2.5 mg weekly (priming — you will not lose much yet)
• Weeks 5–8: 5 mg weekly
• Weeks 9–12: 7.5 mg weekly
• Weeks 13–16: 10 mg weekly
• Weeks 17–20: 12.5 mg weekly
• Week 21+: 15 mg weekly (max)

Most people don't go all the way to 15. A lot of forum logs top out at 7.5 or 10 mg because the weight loss is already happening and the side-effect math tilts. Some people "holding" at lower doses (2.5 or 5 mg) as a long-term maintenance strategy are watching that work well, with less GI noise.

"I was ready for 10 mg to feel like a cliff. It didn't. At 7.5 I lost the weight I needed to lose, and when I tried to push to 10 I spent a week nauseous for no extra benefit. Dropped back, stayed there six months, kept losing." — forum user

What it pairs with

• Resistance training + 0.8–1g protein/lb — the single most important lever for lean mass. DEXA subtudies show ~33% of weight lost is lean mass without it
• Creatine — cheap, effective, muscle-preserving
• 5-Amino-1MQ — adipocyte-level fat metabolism on top of the appetite work
• BPC-157 — community favorite for managing GI symptoms during titration
• Electrolytes, fiber, magnesium — not optional, nausea and constipation are dehydration in disguise

Generally not stacked with other GLP-1s. Pick one incretin, run it right.

Red flags and side effects

• GI: nausea, vomiting, diarrhea, constipation. Peaks after dose increases, settles in 1–2 weeks if titration was right
• Sulfur burps — not dangerous, deeply unpleasant. Hydration and smaller meals help
• Lean mass loss — real, preventable with training and protein
• Gallbladder issues — rapid weight loss increases gallstone risk
• Gastroparesis — rare but serious; if nausea is severe and persistent, that's a flag
• Rebound weight gain — stopping cold almost always means regaining a chunk. Plan for maintenance dosing

The honest limits

• Weight comes back off-drug. The STEP-1 extension with semaglutide showed ~2/3 regain within a year; tirz looks similar. This is, for most people, a long-term medication
• Compounded tirz quality varies wildly. Peptide-grade from a reputable source with a COA is non-negotiable
• The body composition problem isn't a tirz problem — it's a caloric deficit problem. Whatever drug gets you there, the lean mass math is the same
• GIP receptor biology is still debated. Tirz works, but the mechanism story isn't fully closed

Where to go next

• For the trial data, mechanism, and structure details, see the Pepperpedia Tirzepatide entry.
• For live titration logs, side-effect management threads, and the long-running tirz-vs-sema debates, visit the Optimization forum.
• For vial math and syringe unit conversions, PepperCalc handles it.
• Comparing the class? See Semaglutide and Retatrutide.